Myopia is said to be growing into one of the biggest public health challenges in the world, affecting 2.6 billion globally.
Thomson X, a wholly-owned subsidiary of Thomson Medical Group, has inked a strategic partnership with Plano, a Singapore-based healthtech startup.
The collaboration will leverage on the strengths of Thomson X and Plano to address and manage myopia through technological solutions, which Plano specialises in.
